Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its clinical programs comprise ELVN-001, a small molecule kinase inh...
Leadership
Richard A. Fair M.B.A.
CEO, President & Director
Samuel S. Kintz M.B.A.Founder
Co-Founder & Head of Pipeline
Benjamin Hohl
CFO & Head of Corporate Development
Helen Louise Collins M.D.
Chief Medical Officer
Joseph P. Lyssikatos Ph.D.Founder
Co-Founder & Research Fellow
Anish Patel Pharm.D.Founder
Co-Founder & COO
Galya D. Blachman Esq., Ph.D.
Chief Legal Officer & Head of Business Development
